Today: 19 May 2026
Browse Category

TSX:4519 8 July 2025 - 28 November 2025

RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal

RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal

Rani Therapeutics shares traded around $1.59 on 28 November, down from the previous close of $1.62 but still well above pre-October levels. No new press releases or SEC filings were issued today. The stock’s recent surge followed a major Chugai Pharmaceutical collaboration and $60.3 million private placement. Market cap stands near $190–200 million with roughly 97.5 million shares outstanding.
28 November 2025
··
Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Japan Stocks Today: Topix Closes at Record 3,359 as Nikkei Ends at 51,063; Sony’s Upgrade Offsets SoftBank Slump, Yen Nears ¥155

Topix closed at a record 3,359.33, up 1.14%, while the Nikkei 225 rose 0.43% to 51,063.31. SoftBank fell after confirming a $5.8 billion sale of its Nvidia stake; Sony jumped on an 8% profit forecast hike. The yen weakened near ¥155 per dollar. About 78% of Prime market stocks advanced.
12 November 2025
········
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics shares surged over 150% on Oct. 17, 2025, after announcing a collaboration and license deal with Chugai Pharmaceutical worth up to $1.085 billion. The company also raised $60.3 million in PIPE financing, stating it now has funding into 2028. Trading volume spiked to 70 million shares, up from a 300,000 average. Analyst opinions remain split on the stock’s outlook.
18 October 2025
···
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics shares surged nearly 190% to $1.37 on Oct. 17, 2025, after announcing a pharma partnership with Chugai Pharmaceutical worth up to $1.085 billion. The deal includes $10 million upfront, development and sales milestones, and potential royalties. Rani also raised $60.3 million in a private placement, extending its cash runway into 2028. Trading volume spiked to several times the daily average.
17 October 2025
···
The State of AI: Agentic Revolution, Healthcare Breakthroughs & Global Governance / Updated: 2025, July 8th, 12:00 CET

The State of AI: Agentic Revolution, Healthcare Breakthroughs & Global Governance / Updated: 2025, July 8th, 12:00 CET

More than 777 FDA-cleared AI devices are in clinical use for medical imaging in the U.S., cutting scan times and flagging urgent cases. Microsoft's MAI-DxO system reached 85.5% diagnostic accuracy, far above doctors at 20%. The U.S. Senate rejected a 10-year moratorium on state AI regulation. Meta recruited Apple’s Ruoming Pang for its AI push, while Wimbledon 2025 adopted AI-driven line calling amid player criticism.
8 July 2025
······

Stock Market Today

  • Topps Tiles Shares Stable as Turnaround Strategy Shows Progress Amid Market Challenges
    May 19, 2026, 6:02 AM EDT. Topps Tiles (LSE: TPT), a 34p penny stock, reported mixed but positive interim results for 2026, showing stability after a 55% five-year decline. The Mission 365 plan aims to grow sales to £365 million with profitable margins. Adjusted revenue was slightly down 0.2% pro forma, but operating profit rose 17.3%. The company outperformed the UK home improvement market despite inflation and weak consumer sentiment. Management expects revenue to improve in the second half and forecasts modest profit growth if economic conditions hold. Net debt increased to £3.1 million but is supported by a £30 million banking facility. Investors await further clarity on the full-year dividend policy.

Latest articles

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.
Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

19 May 2026
Alphabet shares rose in pre-market trading Tuesday after Google and Blackstone announced a U.S. AI cloud venture, with Blackstone committing $5 billion to add 500 megawatts of data-center capacity by 2027. Alphabet’s Class A shares closed Monday at $396.94 and were quoted at $401.09 before the market opened. The move coincides with the first day of Google I/O and follows strong Q1 earnings.

Popular

USA Rare Earth Drops After Rare-Earth Stocks Stall

USA Rare Earth Drops After Rare-Earth Stocks Stall

18 May 2026
USA Rare Earth shares fell 12.8% to $21.28 Monday, trading nearly 18 million shares as investors pulled back from the volatile rare-earth sector. The drop followed news that defense firms are urging a delay to a ban on Chinese rare-earth magnets in U.S. military contracts. The company reported $5.7 million in first-quarter revenue and received a $14.18 million Texas grant for its Round Top Mountain project.
Go toTop